Genprex Enters Agreement with the University of Texas MD Anderson Cancer Center to Study Oncoprex in Combination with Immunotherapies Read more
KEYTRUDA (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma Read more
PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of Antisense Oligonucleotides Read more
GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines Read more
Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints Read more
Bristol-Myers Squibb, Sandoz, AmerisourceBergen, Genetech and more joining the LogiPharma 2018 Conference Read more